After withdrawing its first attempt at an IPO in September 2008 (citing unfavorable market conditions as its reason), biocatalyst producer Codexis closed out 2009 by filing a new S-1, proposing...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)